Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Ref Type | |||||||||||||
| PMID | |||||||||||||
| Authors | Sonja Loges, Bjorn Torre Gjertsen, Michael Heuser, I Ben-Batalla, David Micklem, Chromik Jorg, Maxim Kebenko, Walter M. Fiedler, Jorge E. Cortes | ||||||||||||
| Title | A first-in-patient phase I study of BGB324, a selective Axl kinase inhibitor in patients with refractory/relapsed AML and high-risk MDS. | ||||||||||||
|
|||||||||||||
| URL | http://meetinglibrary.asco.org/content/170403-176 | ||||||||||||
| Abstract Text | J Clin Oncol 34, 2016 (suppl; abstr 2561) | ||||||||||||
| Molecular Profile | Treatment Approach |
|---|
| Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
|---|
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|
| Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
|---|
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|